Sight is one of our most valued senses, which allows us to connect with the world around us. With age, however, for millions of people, eyesight-related challenges begin with slight blurriness and progressively lead to irreversible vision loss.

Among the many age-related eye conditions, age-related macular degeneration (AMD) is one of the most common causes of vision loss in patients over the age of 50. As life expectancy increases in India, the number of cases of AMD is also rising. This condition often presents with early symptoms. Early counselling and identification are important for managing the condition better. Studies show that our genes play a critical role in determining who develops age-related macular degeneration. Understanding the genetic influence behind age-related blindness can help move toward earlier diagnosis, personalised care, and targeted prevention strategies.

The Genetic Link

 Lifestyle and environmental factors like age, smoking, and poor nutrition are known risk factors for AMD. Genome studies have identified that genetics can also influence who is likely to develop AMD.

In age-related macular degeneration, one of the strongest genetic associations identified is with variations in the CFH (Complement Factor H) gene. This gene plays a role in regulating inflammation in the retina. Certain variants increase susceptibility to chronic inflammation, leading to damage of the macula, the central part of the retina responsible for sharp vision. Other genes, such as ARMS2 and HTRA1, also influence how retinal cells respond to stress and ageing.

Early Detection Can Change the Story

The start of AMD does not mean inevitable blindness. Understanding an individual’s genetic predisposition can enable doctors to recommend appropriate precautions to slow or mitigate its progress. For people with high-risk genetic variants, ophthalmologists can provide individualised recommendations such as:

• More frequent retinal examinations
• Diet modifications, including lutein and zeaxanthin supplementation
• Lifestyle changes that reduce oxidative damage

Why Genetic Insights Matter

Standard eye exams detect visible physical changes but often miss hidden genetic risk factors that may silently influence disease development. Genetic testing empowers individuals to act early, potentially mitigating disease before symptoms worsen. Since AMD often runs in families, knowing one’s genetic risk can also help parents, siblings, and children understand and manage their own risk.

Advances in genetic research are paving the way for personalised ophthalmology. Emerging therapies aim to target specific molecular pathways influenced by genetic variants, particularly in conditions like AMD and inherited retinal disorders. While genetic testing is not yet routine for all age-related eye diseases, it is becoming an important tool in research and selected clinical settings.

From Awareness to Action

Vision loss due to ageing isn’t inevitable. Early detection can help identify AMD early and allow for better management. The first step in protecting sight and quality of life is understanding your genetic risk. Genes play a powerful but modifiable role in age-related blindness. By combining genetic awareness with proactive eye care and healthy ageing strategies, it is possible to preserve vision and quality of life well into later years.